JP2022534159A5 - - Google Patents

Info

Publication number
JP2022534159A5
JP2022534159A5 JP2021541224A JP2021541224A JP2022534159A5 JP 2022534159 A5 JP2022534159 A5 JP 2022534159A5 JP 2021541224 A JP2021541224 A JP 2021541224A JP 2021541224 A JP2021541224 A JP 2021541224A JP 2022534159 A5 JP2022534159 A5 JP 2022534159A5
Authority
JP
Japan
Application number
JP2021541224A
Other languages
Japanese (ja)
Other versions
JP2022534159A (ja
JPWO2020150605A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/014086 external-priority patent/WO2020150605A1/en
Publication of JP2022534159A publication Critical patent/JP2022534159A/ja
Publication of JPWO2020150605A5 publication Critical patent/JPWO2020150605A5/ja
Publication of JP2022534159A5 publication Critical patent/JP2022534159A5/ja
Pending legal-status Critical Current

Links

JP2021541224A 2019-01-18 2020-01-17 微細化した固形メラトニン組成物 Pending JP2022534159A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962794159P 2019-01-18 2019-01-18
US62/794,159 2019-01-18
PCT/US2020/014086 WO2020150605A1 (en) 2019-01-18 2020-01-17 Solid micronized melatonin composition

Publications (3)

Publication Number Publication Date
JP2022534159A JP2022534159A (ja) 2022-07-28
JPWO2020150605A5 JPWO2020150605A5 (https=) 2023-01-20
JP2022534159A5 true JP2022534159A5 (https=) 2023-01-20

Family

ID=71610353

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021541224A Pending JP2022534159A (ja) 2019-01-18 2020-01-17 微細化した固形メラトニン組成物

Country Status (9)

Country Link
US (2) US20200230059A1 (https=)
EP (1) EP3911315A4 (https=)
JP (1) JP2022534159A (https=)
CN (1) CN113490491A (https=)
AU (1) AU2020209940A1 (https=)
BR (1) BR112021013976A2 (https=)
CA (1) CA3126413A1 (https=)
MX (1) MX2021008623A (https=)
WO (1) WO2020150605A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112022012199A2 (pt) * 2020-01-17 2022-09-13 Nestle Sa Forma de dosagem com péletes de melatonina de liberação sustentada
AU2022242966A1 (en) * 2021-03-22 2023-10-05 Fertis India Pvt. Ltd. Agricultural composition comprising melatonin and carboxylic compounds for enhancing antioxidant property to increase crop yield
CA3221463A1 (en) * 2021-06-09 2022-12-15 Agb-Pharma Ab Melatonin formulation in solid dosage form
CA3268494A1 (en) 2022-10-14 2024-04-18 Société des Produits Nestlé S.A. DELAYED-RELEASE MELATONIN COMPOSITIONS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9532952B2 (en) * 2011-01-28 2017-01-03 Physician's Seal, LLC Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
US8691275B2 (en) * 2011-01-28 2014-04-08 Zx Pharma, Llc Controlled-release melatonin compositions and related methods
DK2949322T3 (en) * 2014-05-28 2018-07-23 Valpharma S P A FORMULATION FOR ORAL ADMINISTRATION COMPREHENSIVE MELATONIN IN STABLE FORM AND PROCEDURE FOR PREPARING THEREOF
ES2684414B1 (es) * 2017-03-31 2019-12-11 Laboratorios Vinas S A Composición galénica, para uso oral, que comprende melatonina micronizada y una sal de zinc y método y uso correspondientes

Similar Documents

Publication Publication Date Title
JPWO2022019250A1 (https=)
CN305746572S (https=)
CN305740597S (https=)
CN305535741S (https=)
CN305533812S (https=)
CN305558319S (https=)
CN305533551S (https=)
CN305532357S (https=)
CN305556860S (https=)
CN305531536S (https=)
CN305531213S (https=)
CN305530587S (https=)
CN305530536S (https=)
CN305530230S (https=)
CN305529713S (https=)
CN305529600S (https=)
CN305528670S (https=)
CN305528472S (https=)
CN305527363S (https=)
CN305806953S (https=)
CN305800686S (https=)
CN305797392S (https=)
CN305797065S (https=)
CN305796036S (https=)
CN305765520S (https=)